Physician profile
Vincent Klapper
NPI 1053055384
$264.70
in general payments reported to CMS, 2019-2025
10 companies · $87.66 in 2025
The $87.66 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.32 · 2023: $69.51 · 2024: $70.21 · 2025: $87.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $47.23 | 2023-2024 | Lokelma, Fasenra |
| Dexcom, INC. | $38.74 | 2024 | Dexcom G6 Transmitter |
| Inari Medical, INC. | $27.48 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pharming Healthcare, INC. | $26.50 | 2025 | Ruconest |
| Sobi, INC | $26.27 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.09 | 2025 | |
| Insmed, INC. | $19.62 | 2025 | Arikayce |
| Otsuka America Pharmaceutical, INC. | $18.92 | 2022 | |
| Viiv Healthcare Company | $18.40 | 2022 | |
| Novo Nordisk INC | $17.45 | 2025 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Klapper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.